[1]
Gillis, C.J., Southall, T.M., Wilson, R., Anderson, M., Young, J., Hewitt, R. and Andrews, M. 2022. The value of magnetic resonance imaging-ultrasound fusion targeted biopsies for clinical decision-making among patients with previously negative transrectal ultrasound biopsy and persistent prostate-specific antigen elevation. Canadian Urological Association Journal. 16, 6 (Jan. 2022), E315–20. DOI:https://doi.org/10.5489/cuaj.7509.